ERBB2 and neoplasm: As shown in Figure S2, NR3C2 expression was correlated with several clinicopathological characteristics, including race (P < 0.001), tumor status (P = 0.024), histological type (P < 0.001), PAM50 (P < 0.001), HER2 status (P = 0.007), ER status (P = 0.046), and TP53 status (P < 0.001).